IMF-ONS 2022

Case Studies for Nurses: New Therapies and Regimens for Patients with Multiple Myeloma

Enduring Course Now Available!

This educational activity aims to equip healthcare professionals, particularly nurses, with up-to-date knowledge and practical strategies for managing patients with multiple myeloma. It covers new and emerging therapies such as CELMoDsĀ®, CAR T-cell therapy, and bispecific antibodies, emphasizing adverse event management and patient education. The importance of therapy sequencing, including multidrug regimens and bridging therapy, is discussed alongside strategies to achieve deep responses through treatments like ASCT and maintenance therapy. The session also addresses health equity issues and advocates for shared decision-making between patients, caregivers, and healthcare providers throughout the treatment journey.

About the Symposium:
Join us as we explore the latest in multiple myeloma management! In this 1.5 CNE symposium, four highly experienced nurses will share the most up-to-date strategies for achieving deep treatment responses, managing side effects, overcoming disparities, and fostering shared decision-making. This dynamic event features real-life patient cases to highlight clinical pearls and practical solutions for nurses at all levels. Elevate your practice and empower your patients with the knowledge gained at this symposium.

This activity is intended for nurses engaged in the care of patients with multiple myeloma.